ConductScience.org, home

Paper35864293

Propensity score matching analysis comparing radical prostatectomy and radiotherapy with androgen deprivation therapy in locally advanced prostate cancer.

Lu YC and 13 others. Sci Rep, 2022. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Propensity score matching analysis comparing radical prostatectomy and radiotherapy with androgen deprivation therapy in locally advanced prostate cancer. Papers, record 35864293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35864293

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Propensity score matching analysis comparing radical prostatectomy and radiotherapy with androgen deprivation therapy in locally advanced prostate cancer.
PubMed
Journal
Sci Rep
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.44
iCite
Revised in PubMed
2025-07-28
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lu YCYu-Cheng
2Huang CYChao-Yuan
3Cheng CHChia-Hsien
4Huang KHKuo-How
5Lu YCYu-Chuan
6Chow PMPo-Ming
7Chang YKYi-Kai
8Pu YSYeong-Shiau
9Chen CHChung-Hsin
10Lu SLShao-Lun
11Lan KHKeng-Hsueh
12Jaw FSFu-Shan
13Chen PLPei-Ling
14Hong JHJian-Hua

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Prostatic NeoplasmsMajor topic
Androgen Antagonists
Androgens
Humans
Male
Neoplasm Recurrence, Local
Propensity Score
Prostate-Specific Antigen
Prostatectomy
Retrospective Studies

Source PubMed

Download CSV of topics

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132591157Association between low prostate-specific antigen levels and greater disease progression in high-grade locally-advanced prostate cancer.J Formos Med Assoc2021https://conductscience.org/library/papers/32591157PubMed
231068988Epidemiology of Prostate Cancer.World J Oncol2019https://conductscience.org/library/papers/31068988PubMed
331375279Randomised Trial of Adjuvant Radiotherapy Following Radical Prostatectomy Versus Radical Prostatectomy Alone in Prostate Cancer Patients with Positive Margins or Extracapsular Extension.Eur Urol2019https://conductscience.org/library/papers/31375279PubMed
430585526SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer.Scand J Urol2018https://conductscience.org/library/papers/30585526PubMed
529717358Survival after radical prostatectomy or radiotherapy for locally advanced (cT3) prostate cancer.World J Urol2018https://conductscience.org/library/papers/29717358PubMed
626181727Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer.JAMA Oncol2015https://conductscience.org/library/papers/26181727PubMed
711176485Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database.J Urol2001https://conductscience.org/library/papers/11176485PubMed
833117669Application of Radiomics for the Prediction of Radiation-Induced Toxicity in the IMRT Era: Current State-of-the-Art.Front Oncol2020https://conductscience.org/library/papers/33117669PubMed
918172188Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610.J Clin Oncol2008https://conductscience.org/library/papers/18172188PubMed
1030836166Dose Escalation for Prostate Adenocarcinoma: A Long-Term Update on the Outcomes of a Phase 3, Single Institution Randomized Clinical Trial.Int J Radiat Oncol Biol Phys2019https://conductscience.org/library/papers/30836166PubMed
1128757301Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review.Eur Urol2017https://conductscience.org/library/papers/28757301PubMed
1211422794Discrepancies between Gleason scores of needle biopsy and radical prostatectomy specimens.Pathol Int2001https://conductscience.org/library/papers/11422794PubMed
1329543933Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial.JAMA Oncol2018https://conductscience.org/library/papers/29543933PubMed
1423835712Challenges of guarantee-time bias.J Clin Oncol2013https://conductscience.org/library/papers/23835712PubMed
152293491320-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer.BJU Int2012https://conductscience.org/library/papers/22934913PubMed
1615821485Treatment of patients with high risk localized prostate cancer: results from cancer of the prostate strategic urological research endeavor (CaPSURE).J Urol2005https://conductscience.org/library/papers/15821485PubMed
1726215604Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis.Eur Urol2016https://conductscience.org/library/papers/26215604PubMed
1817698141The significance of positive surgical margin in areas of capsular incision in otherwise organ confined disease at radical prostatectomy.J Urol2007https://conductscience.org/library/papers/17698141PubMed
1933538338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed
2031718822Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials.Eur Urol2020https://conductscience.org/library/papers/31718822PubMed

See all 35 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
39516348
Efficacy and safety of neoadjuvant chemohormonal therapy for high-risk prostate cancer treated with robot-assisted laparoscopic radical prostatectomy: a propensity score-matched analysis (the MSUG94 group).
Int Urol Nephrol2025https://conductscience.org/library/papers/39516348PubMed
39337047Overall Survival and Cancer-Specific Mortality in Patients with Prostate Cancer Undergoing Definitive Therapies: A Narrative Review.J Clin Med2024https://conductscience.org/library/papers/39337047PubMed
39145084Combination approach using neoadjuvant therapy with radical prostatectomy for improving oncological outcomes of high-risk prostate cancer: a narrative review.Transl Cancer Res2024https://conductscience.org/library/papers/39145084PubMed
38784314Assessing the Efficacy and Long-Term Outcomes of Surgical Intervention Versus Radiotherapy: A Comprehensive Systematic Review and Meta-Analysis of Prostate Cancer Treatment Modalities.Cureus2024https://conductscience.org/library/papers/38784314PubMed
37740045Comparing pentafecta outcomes between nerve sparing and non nerve sparing robot-assisted radical prostatectomy in a propensity score-matched study.Sci Rep2023https://conductscience.org/library/papers/37740045PubMed
37240717Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer.Life (Basel)2023https://conductscience.org/library/papers/37240717PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD2004345PubTator's text mininghttps://conductscience.org/library/genes/4345NCBI Gene
KLK3354PubTator's text mininghttps://conductscience.org/library/genes/354NCBI Gene
NPEPPS9520PubTator's text mininghttps://conductscience.org/library/genes/9520NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35864293

GET https://conductscience.org/api/papers/v1/35864293/references?page=2